eGVHD
Graft Versus Host Disease
About
This educational tool assists healthcare professionals in assessing and scoring the severity of graft versus host disease (GVHD) in allogeneic stem cell transplantation recipients. It uses an algorithm-driven approach to apply internationally recognized criteria, providing differential information and automatic summaries to aid diagnosis.
What's New in eGVHD
1.1.1
October 27, 2020
- CE mark (Class I medical device) - Minor changes to the algorithms for scoring gvhd
Developer apps
FAQ
What is eGVHD used for?
eGVHD is an educational tool designed to help clinicians apply internationally recognized criteria for assessing and scoring the severity of graft versus host disease (GVHD) in recipients of allogeneic stem cell transplantation.
Is eGVHD a medical diagnostic tool?
No, eGVHD is not intended to replace a clinician's diagnosis. It serves as a user-friendly educational resource to improve the ability to diagnose and score GVHD severity.
Who developed eGVHD?
The eGVHD App was developed by UZ Leuven (Belgium) in collaboration with the EBMT Transplantation Complications Working Party and the National Institute of Health (USA).
What devices does eGVHD support?
eGVHD is available for iPhone, iPad, and iPod devices.
What is the age rating for eGVHD?
eGVHD has an age rating of 17+, indicating it is intended for mature users.
How often is eGVHD updated?
The latest version of eGVHD is 1.1.1, which was last updated on October 27, 2020. The initial release date was March 7, 2018.
Does eGVHD have ads?
No, eGVHD does not contain advertisements.
What is the user feedback on eGVHD?
eGVHD has received a high rating of 5.0 stars based on 2 user reviews, suggesting positive user sentiment.
